{"id":"follitropin-beta-injection","safety":{"commonSideEffects":[{"rate":"null","effect":"Ovarian hyperstimulation syndrome"},{"rate":"null","effect":"Headache"},{"rate":"null","effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Follitropin beta injection is a recombinant DNA-derived human follicle-stimulating hormone (hFSH) used to stimulate follicular growth in the ovaries.","oneSentence":"Stimulates the production of follicle-stimulating hormone (FSH)","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:00:35.745Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Induction of ovulation in anovulatory infertile women, Assisted reproductive technology"}]},"trialDetails":[{"nctId":"NCT07340827","phase":"PHASE3","title":"A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)","status":"RECRUITING","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2026-02-05","conditions":"Infertility","enrollment":333},{"nctId":"NCT06134479","phase":"PHASE3","title":"Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2023-12-12","conditions":"Fertility","enrollment":194},{"nctId":"NCT07097259","phase":"PHASE1","title":"A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male Participants","status":"COMPLETED","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2025-07-21","conditions":"Hypogonadism","enrollment":55},{"nctId":"NCT06864793","phase":"PHASE1","title":"Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2025-04-06","conditions":"Infertility, Female","enrollment":48},{"nctId":"NCT06173869","phase":"PHASE3","title":"A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2024-03-29","conditions":"Infertility, Female","enrollment":301},{"nctId":"NCT06175832","phase":"PHASE4","title":"PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2025-01-27","conditions":"Ovarian Stimulation, Quality of Life, Preimplantation Genetic Testing","enrollment":60},{"nctId":"NCT04166825","phase":"NA","title":"Ovarian Hyperstimulation and Fibrin Clot Properties.","status":"RECRUITING","sponsor":"Jagiellonian University","startDate":"2019-11-18","conditions":"Fibrin Blood Clot, Infertility, Female, Endometriosis","enrollment":300},{"nctId":"NCT05815719","phase":"PHASE4","title":"Continuous Double Ovarian Stimulation.","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2022-11-17","conditions":"Fertility Issues","enrollment":30},{"nctId":"NCT06966219","phase":"","title":"Trigger Protocol on the Rate of Pregnancy After Intracytoplasmic Sperm Injection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Suez University","startDate":"2025-05-01","conditions":"Infertility","enrollment":90},{"nctId":"NCT06321107","phase":"","title":"Long-term Follow-up Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference","status":"ACTIVE_NOT_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2024-03-01","conditions":"Infertility","enrollment":158},{"nctId":"NCT05263388","phase":"PHASE3","title":"A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2022-07-15","conditions":"Infertility","enrollment":302},{"nctId":"NCT03737253","phase":"NA","title":"Hormone Evaluation in Artificial Reproductive Technology","status":"COMPLETED","sponsor":"Lund University","startDate":"2016-09","conditions":"Female Infertility","enrollment":810},{"nctId":"NCT04773353","phase":"PHASE3","title":"Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Indian Women","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2021-12-03","conditions":"Infertility","enrollment":220},{"nctId":"NCT06778304","phase":"PHASE1","title":"Bioequivalence Clinical Trial of Recombinant Human Follicle-stimulating Hormone JZB30","status":"COMPLETED","sponsor":"West China Second University Hospital","startDate":"2021-01-04","conditions":"Bioequivalence, Healthy Volunteers, Pharmacokinetics","enrollment":48},{"nctId":"NCT05330130","phase":"PHASE1","title":"Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells","status":"COMPLETED","sponsor":"ART Fertility Clinics LLC","startDate":"2023-07-05","conditions":"Ovarian Function Insufficiency, Fertility Issues, Infertility,Female","enrollment":6},{"nctId":"NCT04997525","phase":"PHASE4","title":"Estradiol and Progesterone Levels Following Frozen Embryo Transfer","status":"COMPLETED","sponsor":"Copenhagen University Hospital at Herlev","startDate":"2021-04-20","conditions":"Infertility","enrollment":305},{"nctId":"NCT06091436","phase":"PHASE3","title":"To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-03-24","conditions":"Infertility","enrollment":176},{"nctId":"NCT00703014","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-07-13","conditions":"Pregnancy, Neonates","enrollment":541},{"nctId":"NCT00702338","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-05-15","conditions":"Pregnancy, Neonates","enrollment":1},{"nctId":"NCT00702520","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-01","conditions":"Pregnancy, Neonates","enrollment":15},{"nctId":"NCT00702273","phase":"","title":"Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-19","conditions":"In Vitro Fertilization","enrollment":344},{"nctId":"NCT06571214","phase":"PHASE4","title":"Potential Benefit of r-hLH Addition in Patients Aged 35 to 40 Under Ovarian Stimulation Treatment","status":"NOT_YET_RECRUITING","sponsor":"Nanjing University","startDate":"2024-09-01","conditions":"Infertility","enrollment":300},{"nctId":"NCT00598208","phase":"PHASE2","title":"A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-05-19","conditions":"Fertilization","enrollment":325},{"nctId":"NCT00702806","phase":"PHASE2","title":"Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-07-01","conditions":"Infertility, In Vitro Fertilization","enrollment":99},{"nctId":"NCT06481696","phase":"NA","title":"Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility","status":"RECRUITING","sponsor":"Andros Day Surgery Clinic","startDate":"2024-06-01","conditions":"Unexplained Infertility","enrollment":90},{"nctId":"NCT00696800","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-06-27","conditions":"In Vitro Fertilization","enrollment":1509},{"nctId":"NCT01146418","phase":"PHASE3","title":"Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-06-02","conditions":"Infertility","enrollment":307},{"nctId":"NCT00702845","phase":"PHASE3","title":"To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-12-28","conditions":"Infertility","enrollment":397},{"nctId":"NCT00697255","phase":"PHASE2","title":"A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2007-05-15","conditions":"Ovulation Induction","enrollment":8},{"nctId":"NCT06227949","phase":"PHASE3","title":"FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients","status":"NOT_YET_RECRUITING","sponsor":"Ellen Greenblatt","startDate":"2024-02","conditions":"Fertility Preservation","enrollment":140},{"nctId":"NCT05567731","phase":"NA","title":"Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-10-15","conditions":"Intracytoplasmic Sperm Injection, GnRH Agonist, Infertility","enrollment":30},{"nctId":"NCT04724486","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04724343","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04727684","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Infertility, Intracytoplasmic Sperm Injection","enrollment":50},{"nctId":"NCT04727671","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT02554279","phase":"PHASE4","title":"MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2015-08-31","conditions":"Infertility","enrollment":620},{"nctId":"NCT06048666","phase":"PHASE3","title":"Platelet Rich Plasma on Ovarian Reserve Parameters and Intra Cytoplasmic Sperm Injection Outcomes in Patients With Diminished Ovarian Reserve","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-10-30","conditions":"IVF","enrollment":56},{"nctId":"NCT03564509","phase":"PHASE2","title":"A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2018-05-14","conditions":"Controlled Ovarian Stimulation","enrollment":620},{"nctId":"NCT03296527","phase":"PHASE3","title":"Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2017-12-01","conditions":"Controlled Ovarian Simulation","enrollment":1011},{"nctId":"NCT03228680","phase":"PHASE3","title":"Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2017-07-29","conditions":"Infertility","enrollment":373},{"nctId":"NCT05266924","phase":"PHASE3","title":"Recombinant Follicle-stimulating Hormone in Treatment for Infertility","status":"UNKNOWN","sponsor":"Bharat Serums and Vaccines Limited","startDate":"2022-07-23","conditions":"Female Infertility","enrollment":250},{"nctId":"NCT04931355","phase":"NA","title":"Acupuncture in the Freeze-all IVF Cycle","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2023-06-01","conditions":"Acupuncture, Female Infertility","enrollment":90},{"nctId":"NCT04616729","phase":"PHASE1, PHASE2","title":"DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2022-11-01","conditions":"Breast Cancer Female","enrollment":30},{"nctId":"NCT03197077","phase":"PHASE3","title":"Optimisation of Follicular Recruitment in IVM Cycles","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2017-11-01","conditions":"Infertility, Female, Polycystic Ovary Syndrome","enrollment":145},{"nctId":"NCT05648136","phase":"NA","title":"Immune Profile Analysis and Biomarker Identification in Women With Repeated Implantation Failure or Unexplained Recurrent Spontaneous Miscarriage","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2022-12-02","conditions":"Repeated Embryo Implantation Failure, Recurrent Miscarriage, Immune System","enrollment":150},{"nctId":"NCT02402192","phase":"PHASE4","title":"Type of Gonadotropin and Embryo Kinetics of Development","status":"TERMINATED","sponsor":"IVI Madrid","startDate":"2015-04","conditions":"Infertility","enrollment":201},{"nctId":"NCT04899193","phase":"PHASE1","title":"Pergoveris FD and Liquid China BE Study","status":"COMPLETED","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2021-05-08","conditions":"Healthy","enrollment":72},{"nctId":"NCT03088137","phase":"PHASE3","title":"Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment","status":"COMPLETED","sponsor":"IVFarma LLC","startDate":"2017-02-08","conditions":"Infertility, Female","enrollment":118},{"nctId":"NCT00920361","phase":"","title":"Designated Drug Use Investigation 1 of Follistim Injection (Study P06130)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-11","conditions":"Fertilization in Vitro","enrollment":1664},{"nctId":"NCT00920634","phase":"","title":"Protocol for Drug Use Investigation of Follistim Injection (Study P06132)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-07","conditions":"Anovulation","enrollment":384},{"nctId":"NCT01599494","phase":"PHASE3","title":"An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2014-03","conditions":"Infertility","enrollment":""},{"nctId":"NCT00702624","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05690 (Care Program) (P05710)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-04","conditions":"Pregnancy, Neonates","enrollment":113},{"nctId":"NCT00724789","phase":"","title":"Monitor the Incidence of Congenital Malformations in Infants of Women Who Have Been Treated With Ganirelix (Orgalutran®)(Study 38644)(P05966)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-11","conditions":"Pregnancy, Neonates","enrollment":2066},{"nctId":"NCT00702546","phase":"","title":"Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-12","conditions":"In Vitro Fertilization","enrollment":102},{"nctId":"NCT01144416","phase":"PHASE3","title":"Efficacy and Safety Study of a Single Injection of SCH 900962 Versus Daily recFSH Injections in Women Undergoing Controlled Ovarian Stimulation (Study P06029)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-06","conditions":"Infertility","enrollment":1424},{"nctId":"NCT03300518","phase":"NA","title":"Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient","status":"COMPLETED","sponsor":"Reproductive & Genetic Hospital of CITIC-Xiangya","startDate":"2017-11-15","conditions":"Infertility","enrollment":552},{"nctId":"NCT05149924","phase":"PHASE3","title":"Efficacy and Safety of QL1012 in Women for Assisted Reproductive Treatment","status":"COMPLETED","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2018-10-31","conditions":"Infertility","enrollment":354},{"nctId":"NCT02592031","phase":"PHASE1","title":"Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young Women","status":"COMPLETED","sponsor":"Merckle GmbH","startDate":"2009-02","conditions":"Bioequivalence","enrollment":49},{"nctId":"NCT04854707","phase":"","title":"An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data","status":"COMPLETED","sponsor":"IVFarma LLC","startDate":"2020-01-12","conditions":"Reproductive Issues, Reproductive Disorder, Fertility Disorders","enrollment":5484},{"nctId":"NCT04935073","phase":"PHASE3","title":"Traditional Chinese Medicine Herbs in the Freeze-all IVF Cycle","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2021-06-15","conditions":"Infertility, Female","enrollment":90},{"nctId":"NCT04842825","phase":"PHASE3","title":"Sequential Therapy of TCM Herbs to Improve the Success Rate of IVF-ET in Diminished Ovarian Reserve Patients","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2021-04-15","conditions":"Infertility, Female","enrollment":200},{"nctId":"NCT01820728","phase":"PHASE3","title":"A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F®","status":"COMPLETED","sponsor":"Dong-A ST Co., Ltd.","startDate":"2007-01","conditions":"Infertility, Anovulation","enrollment":93},{"nctId":"NCT02309671","phase":"PHASE2","title":"A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2014-12","conditions":"Infertility","enrollment":159},{"nctId":"NCT03134482","phase":"NA","title":"Comparison of Clinical Outcomes Between IVM and Minimal Stimulation IVF in Patients With PCOS","status":"UNKNOWN","sponsor":"CHA University","startDate":"2017-05-01","conditions":"No Condition","enrollment":240},{"nctId":"NCT02179255","phase":"PHASE1, PHASE2","title":"Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF","status":"UNKNOWN","sponsor":"Center for Human Reproduction","startDate":"2014-08-01","conditions":"Female Infertility Due to Diminished Ovarian Reserve","enrollment":30},{"nctId":"NCT03181685","phase":"PHASE4","title":"Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles","status":"TERMINATED","sponsor":"Andros Day Surgery Clinic","startDate":"2016-12-20","conditions":"Infertility, In Vitro Fertilization","enrollment":60},{"nctId":"NCT04142190","phase":"","title":"Corifollitropin Alfa and Embryo Morphokinetics","status":"COMPLETED","sponsor":"Kinderwunsch Institut GmbH","startDate":"2013-01","conditions":"Infertility","enrollment":1351},{"nctId":"NCT01969201","phase":"PHASE4","title":"FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST)","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2014-01","conditions":"Infertility","enrollment":710},{"nctId":"NCT03177538","phase":"PHASE4","title":"Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders","status":"COMPLETED","sponsor":"D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology","startDate":"2017-09-04","conditions":"Infertility, Female","enrollment":32},{"nctId":"NCT03857230","phase":"PHASE1","title":"The Safety and Pharmacokinetics of Primapur and Gonal-f","status":"COMPLETED","sponsor":"IVFarma LLC","startDate":"2015-10-29","conditions":"Area Under Curve, Pharmacokinetics, Absorption","enrollment":28},{"nctId":"NCT01416987","phase":"","title":"A Korean Post-Marketing Surveillance Study On Pergoveris® (Follitropin Alfa + Lutropin Alfa)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2011-08-14","conditions":"Infertility","enrollment":600},{"nctId":"NCT03686852","phase":"NA","title":"Effect of Recombinant Follicular Stimulating Hormone (FSH) Dosing Following Cori-follitropin Alfa","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2019-05-01","conditions":"Infertility","enrollment":261},{"nctId":"NCT00823472","phase":"PHASE4","title":"Trial Comparing Start Stimulation of Recombinant Follicle Stimulating Hormone (rFSH) on Cycle Day 2 Versus Cycle Day 5 in In Vitro Fertilization (IVF)","status":"TERMINATED","sponsor":"UMC Utrecht","startDate":"2009-01","conditions":"in Vitro Fertilization, Ovulation Induction","enrollment":147},{"nctId":"NCT01882166","phase":"NA","title":"Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment","status":"TERMINATED","sponsor":"St. Olavs Hospital","startDate":"2013-10","conditions":"Infertility, Female","enrollment":20},{"nctId":"NCT01112358","phase":"PHASE2","title":"Lutropin Alfa in Women at Risk of Poor Response","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2005-12-07","conditions":"Ovarian Stimulation","enrollment":58},{"nctId":"NCT02459418","phase":"PHASE1","title":"Comparative Pharmacokinetics of AFOLIA and US Gonal-f® RFF Redi-ject After Single Subcutaneous Application","status":"COMPLETED","sponsor":"Fertility Biotech AG","startDate":"2015-05-07","conditions":"Healthy Volunteers","enrollment":42},{"nctId":"NCT00989781","phase":"NA","title":"Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2009-09","conditions":"Polycystic Ovary Syndrome","enrollment":41},{"nctId":"NCT03535103","phase":"PHASE1","title":"Study on the Safety and Pharmacokinetics of LM001 and Gonal-F® in Healthy Women","status":"UNKNOWN","sponsor":"Alphamab Jilin Co., Ltd.","startDate":"2018-06-01","conditions":"Infertility, Female","enrollment":32},{"nctId":"NCT03506243","phase":"PHASE3","title":"Randomized Controlled Study of Comparing Follitrope Versus Gonal-f in Chinese Infertility Women.","status":"COMPLETED","sponsor":"Hangzhou YuYuan Bioscience Technology Co., Ltd.","startDate":"2015-04","conditions":"Infertility, Female","enrollment":451},{"nctId":"NCT01110707","phase":"PHASE2","title":"A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2005-01-10","conditions":"Infertility, Ovulation Induction","enrollment":131},{"nctId":"NCT02069808","phase":"PHASE4","title":"Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation","status":"COMPLETED","sponsor":"Michigan Reproductive Medicine","startDate":"2014-04","conditions":"Egg Donation","enrollment":38},{"nctId":"NCT01687712","phase":"PHASE3","title":"Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF","status":"COMPLETED","sponsor":"Fertility Biotech AG","startDate":"2013-11-25","conditions":"Infertility","enrollment":1100},{"nctId":"NCT03118830","phase":"PHASE4","title":"Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI","status":"COMPLETED","sponsor":"Cairo University","startDate":"2017-04-21","conditions":"Invitro Fertilization","enrollment":204},{"nctId":"NCT02466204","phase":"PHASE4","title":"Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients","status":"COMPLETED","sponsor":"Vietnam National University","startDate":"2015-06-01","conditions":"Infertility","enrollment":400},{"nctId":"NCT00064987","phase":"PHASE2","title":"Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism","status":"TERMINATED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2001-04","conditions":"Hypogonadism, Kallmann Syndrome","enrollment":19},{"nctId":"NCT03105323","phase":"","title":"Role of Ratio of Progesterone to Number of Follicles as a Prognostic Tool for IntracytoplasmicSperm Injection Outcome","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2017-05-01","conditions":"Infertility, Female","enrollment":40},{"nctId":"NCT03071172","phase":"PHASE3","title":"Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET","status":"UNKNOWN","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2017-03","conditions":"Ovarian Hyperstimulation Syndrome","enrollment":252},{"nctId":"NCT01871532","phase":"PHASE4","title":"Low-dose Gonal-f® in Ovulation Induction","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2013-07","conditions":"Infertility, Monofollicular Development","enrollment":24},{"nctId":"NCT01590173","phase":"PHASE2, PHASE3","title":"Addition of Prednisolone and Heparin in Patients Undergoing IVF With Failed IVF Cycles","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2012-01","conditions":"Infertility","enrollment":86},{"nctId":"NCT02719093","phase":"PHASE4","title":"Role of FSHR Polymorphism p.N680S in the Therapy With FSH in Patients Who Underwent Varicocele Surgery","status":"UNKNOWN","sponsor":"U.O. Chirurgia Andrologica","startDate":"2016-07","conditions":"Infertility, Male, Varicocele","enrollment":100},{"nctId":"NCT02673632","phase":"","title":"The Influence of AMH on Ovarian Responsiveness to Ovulation Induction With GnRH in Women With PCOS","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2016-02","conditions":"Infertility","enrollment":30},{"nctId":"NCT02635607","phase":"NA","title":"Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist Protocol","status":"UNKNOWN","sponsor":"Chong Qing Reproducive and Genetic Institute","startDate":"2016-01","conditions":"Infertility","enrollment":200},{"nctId":"NCT01497197","phase":"PHASE3","title":"A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2012-05","conditions":"Infertility, Fertility, Follicle Stimulating Hormone Deficiency","enrollment":174},{"nctId":"NCT01923194","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2013-10","conditions":"Anovulation","enrollment":215},{"nctId":"NCT02213627","phase":"PHASE4","title":"Use of Corifolitropin Alfa in Oocyte Donors","status":"UNKNOWN","sponsor":"IVI Madrid","startDate":"2014-10","conditions":"Female Reproductive Problem, Infertility","enrollment":300},{"nctId":"NCT01204840","phase":"PHASE2","title":"Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)","status":"COMPLETED","sponsor":"Ottawa Fertility Centre","startDate":"2010-09","conditions":"Infertility, Poor Ovarian Reserve","enrollment":38},{"nctId":"NCT02471677","phase":"PHASE4","title":"Corifollitropin Alfa Versus Follitropin Beta in High Responders","status":"UNKNOWN","sponsor":"Eugonia","startDate":"2015-09","conditions":"Infertility","enrollment":62},{"nctId":"NCT01922193","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2013-10","conditions":"Infertility","enrollment":263},{"nctId":"NCT00335725","phase":"PHASE3","title":"Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2003-03","conditions":"Infertility","enrollment":151},{"nctId":"NCT02335879","phase":"PHASE3","title":"Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2008-05","conditions":"Anovulation","enrollment":534}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ABDOMINAL PAIN"},{"count":1,"reaction":"ASCITES"},{"count":1,"reaction":"OVARIAN HYPERSTIMULATION SYNDROME"},{"count":1,"reaction":"PLEURAL EFFUSION"}],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Follistim®","Puregon®"],"phase":"phase_2","status":"active","brandName":"Follitropin beta injection","genericName":"Follitropin beta injection","companyName":"Organon and Co","companyId":"organon-and-co","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Stimulates the production of follicle-stimulating hormone (FSH) Used for Induction of ovulation in anovulatory infertile women, Assisted reproductive technology.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}